CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.5850
-0.0070 (-1.18%)
At close: Mar 13, 2026, 4:00 PM EDT
0.5967
+0.0117 (2.00%)
After-hours: Mar 13, 2026, 4:06 PM EDT

CollPlant Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-12.16-16.61-7.02-16.930.24-5.77
Depreciation & Amortization
0.941.041.11.080.770.66
Stock-Based Compensation
1.441.721.942.171.61.67
Other Adjustments
-0.02-0.01-0.01-0.09-0.18-0.04
Change in Receivables
0.07-0.150.010.260.56-0.75
Changes in Inventories
-0.080.280.75-0.310.18-0.37
Changes in Accounts Payable
-0.39-0.11-0.150.10.24-0.04
Changes in Accrued Expenses
-0.04-0.350.20.01-0.460.74
Changes in Unearned Revenue
----0.03-0.18-0.74
Changes in Other Operating Activities
0.5-0.040.04-0.57-0.120.24
Operating Cash Flow
-9.94-14.09-2.76-13.72.5-4.45
Capital Expenditures
-0.07-0.48-0.95-1.27-1.43-0.44
Sale of Property, Plant & Equipment
000.07-0.03-
Purchases of Intangible Assets
----0.04-0.16-0.08
Purchases of Investments
----20-30-
Proceeds from Sale of Investments
---50.24--
Other Investing Activities
--0.06-0.27---
Investing Cash Flow
-0.07-0.54-1.1628.92-31.56-0.52
Long-Term Debt Repaid
------0.02
Net Long-Term Debt Issued (Repaid)
------0.02
Issuance of Common Stock
1.550.011.111.8738.764.49
Net Common Stock Issued (Repurchased)
1.550.011.111.8738.764.49
Financing Cash Flow
3.10.011.111.8738.764.47
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.09-0.14-0.38-0.610.140.06
Net Cash Flow
-6.82-14.77-3.1916.499.85-0.45
Free Cash Flow
-7.14-14.58-3.72-14.971.07-4.89
FCF Margin
-288.28%-2830.29%-33.92%-5007.36%6.86%-79.65%
Free Cash Flow Per Share
-0.01-1.27-0.34-1.670.09-0.71
Levered Free Cash Flow
-11.3-16.28-6.03-17.93-0.76-5.74
Unlevered Free Cash Flow
11.5217.588.516.09-0.93-5.54
Updated Nov 26, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q